Delivery Order SPE2DB24D6044-SPE2DB25FLJLS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count units) on September 10, 2025, with a ceiling value of $4,911.62 and ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,472.20 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets (500-count units). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with performance to be completed by November 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 14, 2025, for Cetirizine HCL 10 mg tablets (100-count) with a ceiling value of $1,088.45. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency awarded a $1,268.45 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Cetirizine HCL 5 mg tablets (100 count). The contract is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,165.37 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages). The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was not set aside for any specific business category and was competitively awarded. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for cetirizine HCL 5 mg tablets (100-count) with a ceiling value of $2,819.59 under a firm fixed price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count) with a contract value of $4,896.02 and an ultimate completion date of October 31, 2025. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.98 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets in quantities of 300 units. The contract was competitively awarded without set-aside designation and is classified as a firm fixed-price delivery order with an ultimate completion date of November 21, 2025. This award was issued on November 20, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,787 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award from the agency's Medical Supply Chain operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100-count units) under a firm fixed-price contract valued at $2,890.91. The delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJLSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count) valued at $12,245.13 under a firm fixed price arrangement. The award, issued September 5, 2025, with completion expected by September 8, 2025, represents a non-competitive delivery order against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's contract portfolio demonstrates extensive experience fulfilling federal medical supply requirements across multiple therapeutic domains, positioning it as a key vendor within the Department of Defense's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 9/5/25 |